pulmonary%20arterial%20hypertension
PULMONARY ARTERIAL HYPERTENSION
Pulmonary arterial hypertension is a syndrome resulting from restricted flow through the pulmonary arterial circulation resulting in increased pulmonary vascular resistance and ultimately leading to right heart failure.
It is a part of the spectrum of pulmonary hypertension, which is hemodynamic and pathophysiological condition defined as an increase in mean pulmonary arterial pressure ≥25 mmHg at rest.
Typical symptoms include progressive dyspnea on exertion, palpitations, fatigue, weakness, angina, syncope and abdominal distention.
  1. Doyle RL, McCrory D, Channick RN, et al. Surgical treatments/interventions for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest. 2004 Jul;126(1)(Suppl):63S-71S. PMID: 15249495
  2. Badesch DB, Abman SH, Ahearn GS, et al. Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest. 2004 Jul;126(1)(Suppl):35S-62S. PMID: 15249494
  3. McGoon M, Gutterman D, Steen V, et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest. 2004 Jul;126(1)(Suppl):14S-34S. PMID: 15249493
  4. Galiè N, Seeger W, Naeije R, et al. Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension. J Am Coll Cardiol. 2004 Jun;43(12)(Suppl S):81S-88S. PMID: 15194183
  5. Nauser TD, Stites SW. Diagnosis and treatment of pulmonary hypertension. Am Fam Physician. 2001 May;63(9):1789-1798. PMID: 11352291
  6. McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol. 2009 Apr;53(17):1573-1619. PMID: 19389575
  7. The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2009 Oct;30(20):2493-2537. PMID: 19713419
  8. Simonneau G, Galiè N, Rubin LJ, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2004 Jun;43(12)(Suppl S):5S-12S. PMID: 15194173
  9. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. Eur Heart J. 2004 Dec;25(24):2243-2278. PMID: 15589643
  10. Channick RN, Rubin LJ. Pulmonary vasculitis and pulmonary hypertension. In: Mason RJ, Murray JF, Broaddus VC, et al. eds. Murray and Nadel’s Textbook of Respiratory Medicine. 4th ed. Philadelphia: Elsevier Saunders; 2005:1465-1474
  11. MedWormhttp://www.medworm.com/rss/index.php/Cardiology/7/http://www.medworm.com/rss/medicalfeeds/specialities/Cardiology.xml
  12. MedWormhttp://www.medworm.com/rss/index.php/Pediatrics/33/http://www.medworm.com/rss/medicalfeeds/specialities/Pediatrics.xml
  13. MedWormhttp://www.medworm.com/rss/index.php/Respiratory-Medicine/40/http://www.medworm.com/rss/medicalfeeds/specialities/Respiratory-Medicine.xml
  14. Medworm - Pulmonary Hypertensionhttp://www.medworm.com/rss/medicalfeeds/conditions/Pulmonary-Hypertension.xml
  15. McCrory DC, Coeytaux RR, Schmit KM, et al. Pulmonary Arterial Hypertension: Screening, Management, and Treatment. Comparative Effectiveness Review No. 117. AHRQ. Publication No. 13-EHC087-EF. Rockville, MD: Agency for Healthcare Research and Quality; 2013 Apr. http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0056718/pdf/TOC.pdf. Accessed 23 Apr 2014.
  16. Hopkins W, Rubin LJ. Treatment of pulmonary hypertension in adults. UpToDate. http://www.uptodate.com/contents/treatment-of-pulmonary-hypertension-in-adults. Mar 2014. Accessed 23 Apr 2014.
  17. Galiè N, Corris PA, Frost A, et al. Updated treatment algorithm of pulmonary arterial hypertension. J Am Coll Cardiol. 2013 Dec;62(Suppl 25):D60-72. http://content.onlinejacc.org/data/Journals/JAC/929484/10031.pdf. Accessed 17 Jul 2014. PMID: 24355643
  18. Simonneau G, Gatzoulis MA, Adatia I, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013 Dec;62(Suppl 25):D34-41. http://content.onlinejacc.org/data/Journals/JAC/929484/10029.pdf. Accessed 17 Jul 2014. PMID: 24355639
  19. US Food and Drug Administration. Press Announcements: FDA Approves Opsumit to treat pulmonary arterial hypertension. US Food and Drug Administration website. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm371362.htm. Oct 2013.
  20. Patel T, McKeage K. Macitentan: first global approval. Drugs. 2014 Jan;74(1):127-133. doi: 10.1007/s40265-013-0156-6. PMID: 24297706
  21. Galiè N, Humbert M, Vachiery JL, et al; Authors/Task Force Members. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2015 Aug. http://eurheartj.oxfordjournals.org/content/ehj/early/2015/10/21/eurheartj.ehv317.full.pdf. PMID: 26320113
  22. Kamangar N. Secondary pulmonary hypertension treatment & management. eMedicine. http://emedicine.medscape.com/article/303098-treatment. Oct 2015.
  23. McLaughlin VV, Channick R, Chin K, et al. Effect of selexipag on mobidity/mortality in pulmonary arterial hypertension: results of GRIPHON study. J Am Coll Cardiol. 2015 Dec;373(26):2522-2533. doi:10.1016/S0735-1097(15)61538-8. PMID: 26699168
  24. Taichman DB, Ornelas J, Chung L, et al. Pharmacologic therapy for pulmonary arterial hypertension in adults: CHEST guideline and expert panel report. Chest. 2014 Aug;146(2):449-475. doi: 10.1378/chest.14-0793. PMID: 24937180
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Pearl Toh, 19 Jun 2016
Infants with persistent rhinitis have a higher abundance of Actinobacteria, especially Corynebacterium spp., in their nasal microbiome compared with healthy controls, according to a Singapore-based study presented at the European Academy of Allergy and Clinical Immunology (EAACI) Annual Congress 2016 held in Vienna, Austria.
29 Nov 2017
Lansoprazole, a widely available and commonly prescribed proton pump inhibitor (PPI), appears to reduce the incidence of tuberculosis disease, a recent study has found.
Gabriel Angelo Sembrano, 16 Sep 2014

“At present, there is a limited development of new antibiotics. There is also a fast development of resistance to antibiotics. There are pathogens no longer susceptible to all antibiotics, and many pathogens are no longer susceptible to most antibiotics,” said Dr. Andre Villanueva, chief of party of the USAID’s Innovations and Multisectoral Partnerships to Achieve Control of TB (IMPACT) Project at the recent Annual Convention of the Philippine Pharmacists’ Association in Davao City.

Audrey Abella, 06 Jan 2017
Persistent wheeze or childhood asthma may be reduced by fish oil supplementation, particularly n-3 long-chain polyunsaturated fatty acids (LCPUFAs), during pregnancy, a recent Danish study found.